GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » 5-Year Yield-on-Cost %

Santhera Pharmaceuticals Holding AG (XSWX:SANN) 5-Year Yield-on-Cost % : 0.00 (As of May. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG 5-Year Yield-on-Cost %?

Santhera Pharmaceuticals Holding AG's yield on cost for the quarter that ended in Jun. 2023 was 0.00.


The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost % or its related term are showing as below:



XSWX:SANN's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.615
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost % falls into.



Santhera Pharmaceuticals Holding AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Santhera Pharmaceuticals Holding AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Santhera Pharmaceuticals Holding AG  (XSWX:SANN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Santhera Pharmaceuticals Holding AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Traded in Other Exchanges
Address
Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines